Skip to main content

and
  1. Article

    Open Access

    A High-Fat Diet Increases Activation of the Glucagon-Like Peptide-1-Producing Neurons in the Nucleus Tractus Solitarii: an Effect that is Partially Reversed by Drugs Normalizing Glycemia

    Glucagon-like peptide-1 (GLP-1) is a peripheral incretin and centrally active peptide produced in the intestine and nucleus tractus solitarii (NTS), respectively. GLP-1 not only regulates metabolism but also i...

    Grazyna Lietzau, Stelia Ntika, Hiranya Pintana in Cellular and Molecular Neurobiology (2022)

  2. Article

    Open Access

    The Stroke-Induced Increase of Somatostatin-Expressing Neurons is Inhibited by Diabetes: A Potential Mechanism at the Basis of Impaired Stroke Recovery

    Type 2 diabetes (T2D) hampers recovery after stroke, but the underling mechanisms are mostly unknown. In a recently published study (Pintana et al. in Clin Sci (Lond) 133(13):1367–1386, 2019), we showed that i...

    Fausto Chiazza, Hiranya Pintana, Grazyna Lietzau in Cellular and Molecular Neurobiology (2021)

  3. Article

    Open Access

    The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway

    Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) are approved drugs for the treatment of hyperglycemia in patients with type 2 diabetes. These effects are mainly mediated by inhibiting endogenous glucagon-...

    Fausto Chiazza, Harald Tammen, Hiranya Pintana in Cardiovascular Diabetology (2018)

  4. Article

    Open Access

    Type 2 diabetes impairs odour detection, olfactory memory and olfactory neuroplasticity; effects partly reversed by the DPP-4 inhibitor Linagliptin

    Recent data suggest that olfactory deficits could represent an early marker and a pathogenic mechanism at the basis of cognitive decline in type 2 diabetes (T2D). However, research is needed to further charact...

    Grazyna Lietzau, William Davidsson in Acta Neuropathologica Communications (2018)

  5. Article

    Open Access

    Vagus Nerve Stimulation Exerts the Neuroprotective Effects in Obese-Insulin Resistant Rats, Leading to the Improvement of Cognitive Function

    Vagus nerve stimulation (VNS) therapy was shown to improve peripheral insulin sensitivity. However, the effects of chronic VNS therapy on brain insulin sensitivity, dendritic spine density, brain mitochondrial...

    Titikorn Chunchai, Bencharunan Samniang, Jirapas Sripetchwandee in Scientific Reports (2016)

  6. No Access

    Article

    Testosterone replacement attenuates cognitive decline in testosterone-deprived lean rats, but not in obese rats, by mitigating brain oxidative stress

    Testosterone replacement improves metabolic parameters and cognitive function in hypogonadism. However, the effects of testosterone therapy on cognition in obese condition with testosterone deprivation have no...

    Hiranya Pintana, Wanpitak Pongkan, Wasana Pratchayasakul, Nipon Chattipakorn in AGE (2015)

  7. No Access

    Article

    Testosterone deficiency, insulin-resistant obesity and cognitive function

    Testosterone is an androgenic steroid hormone, which plays an important role in the regulation of male reproduction and behaviors, as well as in the maintenance of insulin sensitivity. Several studies showed t...

    Hiranya Pintana, Nipon Chattipakorn, Siriporn Chattipakorn in Metabolic Brain Disease (2015)

  8. No Access

    Article

    Protective effects of garlic extract on cardiac function, heart rate variability, and cardiac mitochondria in obese insulin-resistant rats

    Garlic has been shown to exhibit antioxidant effects and cardioprotective properties. However, the effects of garlic extract on the heart in insulin resistance induced by long-term high-fat-diet consumption ar...

    Luerat Supakul, Hiranya Pintana, Nattayaporn Apaijai in European Journal of Nutrition (2014)